Glecirasib
Glecirasib (Compound 1-2; JAB-21822) is an orally active and potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. Glecirasib has the potential for the research of KRAS G12C-mediated cancer[1][2][3][4].
Product Specifications
CAS Number
2657613-87-9
Product Name Alternative
JAB-21822; KRAS G12C inhibitor 36
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/glecirasib.html
Purity
99.20
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N#CC1=C(N2CCN(CC2)C(C=C)=O)C3=C(N=C(C4=C(N)C(F)=C(F)C(F)=C4F)C(Cl)=C3)N(C5=C(C)C=CN=C5C(C)C)C1=O
Molecular Formula
C31H26ClF4N7O2
Molecular Weight
640.03
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
UBQLN4P sgRNA CRISPR Lentivector (Human) (Target 1)
Napsa sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
